Damora Therapeutics (DMRA) Net Cash Flow Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - | 11,571.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,571.71% |
| Dec 31, 2025 | 111.68% |
| Sep 30, 2025 | 29.48% |
| Jun 30, 2025 | -221.05% |
| Mar 31, 2025 | -860.00% |
| Dec 31, 2024 | -160.91% |
| Sep 30, 2024 | -184,450.00% |
| Jun 30, 2024 | 190.05% |
| Mar 31, 2024 | 96.75% |
| Dec 31, 2023 | -163.90% |
| Sep 30, 2023 | 100.18% |
| Jun 30, 2023 | 85.83% |
| Mar 31, 2023 | 54.70% |
| Dec 31, 2022 | 186.25% |
| Sep 30, 2022 | 47.40% |
| Jun 30, 2022 | -146.34% |
| Mar 31, 2022 | 80.85% |
| Dec 31, 2021 | -104.42% |
| Sep 30, 2021 | -104.46% |
| Jun 30, 2021 | 15.22% |
| Mar 31, 2021 | -380.16% |
| Dec 31, 2020 | 1,571.03% |